Filter by tags: India Clear all tag filters
4 news articles found
China's new-generation tokamak, Huanliu-3 (HL-3), has made significant progress operating in high-confinement mode (H mode) under a plasma current of 1 million amperes for the first time, China National Nuclear Corporation (CNNC) announced. The experiment took place at CNNC’s Southwestern Institute of Physics (SWIP) in Chengdu, Sichuan Province. It is not clear whether this refers to the HL-2M tokamak, which was commissioned at SWIP in December 2020 as an upgrade of the earlier the HL-2A or whether this is a further upgrade.
- Source: NEI Magazine
- Date: Thursday, 07 September 2023
- Original article: neimagazine.com/news/newsmore-fusion-progress-for-china-11124388
Researchers at the Joint European Torus in the UK doubled previous records by producing a total of 59 megajoules of heat energy from fusion over a five second period.
- Source: World Nuclear News
- Date: Thursday, 10 February 2022
- Original article: world-nuclear-news.org/Articles/Fusion-energy-record-at-JET-huge-step-forward
After a decade of design and fabrication, US-based General Atomics said on 15 June that it is ready to ship the first module of the Central Solenoid to the International Thermonuclear Experimental Reactor (ITER) under construction in Saint-Paul-lès-Durance in southern France. Despite the challenges of Covid-19, ITER is almost 75% built and massive first-of-a-kind components have been arriving in France from three continents over the past 15 months. Construction of ITER is funded mainly by the European Union (45.6%) with the remainder shared equally by China, India, Japan, Korea, Russia and the USA (9.1% each). However, in practice, the members deliver little monetary contribution to the project, instead providing ‘in-kind’ contributions of components, systems or buildings.
- Source: NEI Magazine
- Date: Wednesday, 16 June 2021
- Original article: neimagazine.com/news/newsgeneral-atomics-prepares-to-ship-first-module-of-iters-central-solenoid-8822680
A production line at India’s Bhabha Atomic Research Centre (BARC) in Trombay is producing medical products based on caesium-137 instead of the usual cobalt-60, with a range of benefits. A rare but usually fatal complication from blood transfusion, Transfusion-Associated Graft Versus Host Disease, is a major risk for fetuses and very premature newborns, as well as patients with suppressed immune systems. To protect against this, doctors routinely irradiate donated blood either with x-rays or gamma rays sourced from cobalt-60.
- Source: NEI Magazine
- Date: Friday, 24 February 2017
- Original article: neimagazine.com/news/newsindia-develops-medical-products-using-caesium-137-5748486